Connection

Shikhar Mehrotra to T-Lymphocytes

This is a "connection" page, showing publications Shikhar Mehrotra has written about T-Lymphocytes.
Connection Strength

3.962
  1. CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
    View in: PubMed
    Score: 0.518
  2. Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity. Cell Rep. 2019 08 13; 28(7):1879-1893.e7.
    View in: PubMed
    Score: 0.511
  3. Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 06 07; 294(23):9198-9212.
    View in: PubMed
    Score: 0.499
  4. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
    View in: PubMed
    Score: 0.483
  5. CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
    View in: PubMed
    Score: 0.452
  6. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal. 2013 Apr 20; 18(12):1497-534.
    View in: PubMed
    Score: 0.318
  7. T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine. 2011 Aug; 55(2):307-17.
    View in: PubMed
    Score: 0.289
  8. Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function. Cancer Res. 2022 05 16; 82(10):1969-1990.
    View in: PubMed
    Score: 0.155
  9. Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T?cell response. Cell Rep. 2021 05 04; 35(5):109076.
    View in: PubMed
    Score: 0.144
  10. CD38: T Cell Immuno-Metabolic Modulator. Cells. 2020 07 17; 9(7).
    View in: PubMed
    Score: 0.136
  11. Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease. J Clin Invest. 2019 05 02; 129(7):2760-2774.
    View in: PubMed
    Score: 0.125
  12. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018 07 02; 128(7):2787-2801.
    View in: PubMed
    Score: 0.117
  13. Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death. Cancer Res. 2016 10 15; 76(20):6006-6016.
    View in: PubMed
    Score: 0.105
  14. Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway. Leukemia. 2022 07; 36(7):1907-1915.
    View in: PubMed
    Score: 0.039
  15. Identification of human CD4+ T cell populations with distinct antitumor activity. Sci Adv. 2020 07; 6(27).
    View in: PubMed
    Score: 0.034
  16. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27; 5(174):174ra28.
    View in: PubMed
    Score: 0.020
  17. Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma. Clin Dermatol. 2009 Nov-Dec; 27(6):603-13.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.